Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

Tekijä Thum, Thomas, Springer, Jochen
Julkaistu 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

Tekijä Schanze, Nancy, Springer, Jochen
Julkaistu 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

Tekijä Tschirner, Anika, Springer, Jochen
Julkaistu 2012

MicroRNAs in muscle wasting

Tekijä Suzuki, Tsuyoshi, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

Tekijä Palus, Sandra, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

Tekijä Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

Tekijä Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

Tekijä Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

Tekijä Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

Tekijä Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Julkaisussa ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

Tekijä Lena, Alessia, Anker, Markus S., Springer, Jochen
Julkaisussa Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

Tekijä Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Julkaistu 2014

Blocking myostatin: muscle mass equals muscle strength?

Tekijä Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

Tekijä Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

Tekijä Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

Tekijä Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

Tekijä Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

Tekijä Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

Tekijä Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

Tekijä Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Julkaisussa J Cachexia Sarcopenia Muscle (2016)